{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreifsjgdlhmp2aceozh63r4xmkh6mevfp52uc53uvxwpnflsbe2rhli",
    "uri": "at://did:plc:5ka4qkui7nvjms7idhte2m4o/app.bsky.feed.post/3ml7y2msgk332"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreibie64cj6uqyc2yz36ojw62l6uslxlyivyv26fstnconeifatcs3a"
    },
    "mimeType": "image/jpeg",
    "size": 60064
  },
  "path": "/2026/05/06/most-favored-nation-drug-price-savings-estimated-529-billion/?utm_campaign=rss",
  "publishedAt": "2026-05-06T17:03:39.000Z",
  "site": "https://www.statnews.com",
  "tags": [
    "Politics",
    "biotechnology",
    "Congress",
    "drug pricing",
    "Pharmaceuticals",
    "Policy",
    "STAT+",
    "White House"
  ],
  "textContent": "Administration report on most-favored nation drug pricing raises new details — and questions.",
  "title": "STAT+: Administration report on most favored nation drug pricing raises new details — and questions",
  "updatedAt": "2026-05-06T17:32:11.000Z"
}